These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
435 related items for PubMed ID: 15753987
1. Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan. Li JW, Chuang TC, Yang AH, Hsu CK, Kao MC. Int J Oncol; 2005 Apr; 26(4):933-43. PubMed ID: 15753987 [Abstract] [Full Text] [Related]
2. [Expression of Her2/neu in locally advanced bladder cancer: implication for a molecular targeted therapy]. Wülfing C, von Struensee D, Bierer S, Bögemann M, Hertle L, Eltze E. Aktuelle Urol; 2005 Sep; 36(5):423-9. PubMed ID: 16163605 [Abstract] [Full Text] [Related]
3. Amplification and overexpression of HER2/neu gene and HER2/neu protein in salivary duct carcinoma of the parotid gland. Cornolti G, Ungari M, Morassi ML, Facchetti F, Rossi E, Lombardi D, Nicolai P. Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1031-6. PubMed ID: 17938328 [Abstract] [Full Text] [Related]
7. Topoisomerase IIalpha gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study. Kanta SY, Yamane T, Dobashi Y, Mitsui F, Kono K, Ooi A. Hum Pathol; 2006 Oct; 37(10):1333-43. PubMed ID: 16949920 [Abstract] [Full Text] [Related]
8. Determination of HER2/neu status in uterine serous papillary carcinoma: Comparative analysis of immunohistochemistry and fluorescence in situ hybridization. Santin AD, Bellone S, Van Stedum S, Bushen W, De Las Casas LE, Korourian S, Tian E, Roman JJ, Burnett A, Pecorelli S. Gynecol Oncol; 2005 Jul; 98(1):24-30. PubMed ID: 15894362 [Abstract] [Full Text] [Related]
13. Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in-situ hybridization in the evaluation of HER-2/neu expression in primary breast carcinoma. Tawfik OW, Kimler BF, Davis M, Donahue JK, Persons DL, Fan F, Hagemeister S, Thomas P, Connor C, Jewell W, Fabian CJ. Histopathology; 2006 Feb; 48(3):258-67. PubMed ID: 16430472 [Abstract] [Full Text] [Related]
16. Expression levels and clinical-pathological correlations of HER2/neu in primary and metastatic human breast cancer. Stefano R, Agostara B, Calabrò M, Campisi I, Ravazzolo B, Traina A, Miele M, Castagnetta L. Ann N Y Acad Sci; 2004 Dec; 1028():463-72. PubMed ID: 15650272 [Abstract] [Full Text] [Related]
20. HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry. Pellegrini C, Falleni M, Marchetti A, Cassani B, Miozzo M, Buttitta F, Roncalli M, Coggi G, Bosari S. Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3645-52. PubMed ID: 14506153 [Abstract] [Full Text] [Related] Page: [Next] [New Search]